|
1
|
Menon J and Mishra P: Health care resource
use, health care expenditures and absenteeism costs associated with
osteoarthritis in US healthcare system. Osteoarthritis Cartilage.
26:480–484. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Safiri S, Kolahi AA, Smith E, Hill C,
Bettampadi D, Mansournia MA, Hoy D, Ashrafi-Asgarabad A,
Sepidarkish M, Almasi-Hashiani A, et al: Global, regional and
national burden of osteoarthritis 1990-2017: A systematic analysis
of the global burden of disease study 2017. Ann Rheum Dis.
79:819–828. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Brosseau L, Taki J, Desjardins B, Thevenot
O, Fransen M, Wells GA, Imoto AM, Toupin-April K, Westby M,
Gallardo ICÁ, et al: The Ottawa panel clinical practice guidelines
for the management of knee osteoarthritis. Part one: Introduction,
and mind-body exercise programs. Clin Rehabil. 31:582–595.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kolasinski SL, Neogi T, Hochberg MC, Oatis
C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D,
et al: 2019 American college of rheumatology/arthritis foundation
guideline for the management of osteoarthritis of the hand, hip,
and knee. Arthritis Rheumatol. 72:220–233. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jenei-Lanzl Z, Meurer A and Zaucke F:
Interleukin-1β signaling in osteoarthritis-chondrocytes in focus.
Cell Signal. 53:212–223. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Finnson KW, Chi Y, Bou-Gharios G, Leask A
and Philip A: TGF-b signaling in cartilage homeostasis and
osteoarthritis. Front Biosci (Schol Ed). 4:251–268. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Abusarah J, Benabdoune H, Shi Q, Lussier
B, Martel-Pelletier J, Malo M, Fernandes JC, de Souza FP, Fahmi H
and Benderdour M: Elucidating the role of protandim and 6-gingerol
in protection against osteoarthritis. J Cell Biochem.
118:1003–1013. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kovács B, Vajda E and Nagy EE: Regulatory
effects and interactions of the Wnt and OPG-RANKL-RANK signaling at
the bone-cartilage interface in osteoarthritis. Int J Mol Sci.
20(4653)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bai M, Ge L, Chen H and Jin Q: Calcitonin
protects rat chondrocytes from IL-1β injury via the Wnt/β-catenin
pathway. Exp Ther Med. 18:2079–2085. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Miyatake K, Kumagai K, Imai S, Yamaguchi Y
and Inaba Y: Sclerostin inhibits interleukin-1β-induced late stage
chondrogenic differentiation through downregulation of
Wnt/β-catenin signaling pathway. PLoS One.
15(e0239651)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McBride JD, Rodriguez-Menocal L, Guzman W,
Candanedo A, Garcia-Contreras M and Badiavas EV: Bone marrow
mesenchymal stem cell-derived CD63+ exosomes transport
Wnt3a exteriorly and enhance dermal fibroblast proliferation,
migration, and angiogenesis in vitro. Stem Cells Dev. 26:1384–1398.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yasuhara R, Ohta Y, Yuasa T, Kondo N,
Hoang T, Addya S, Fortina P, Pacifici M, Iwamoto M and
Enomoto-Iwamoto M: Roles of β-catenin signaling in phenotypic
expression and proliferation of articular cartilage superficial
zone cells. Lab Invest. 91:1739–1752. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nalesso G, Sherwood J, Bertrand J, Pap T,
Ramachandran M, De Bari C, Pitzalis C and Dell'accio F: WNT-3A
modulates articular chondrocyte phenotype by activating both
canonical and noncanonical pathways. J Cell Biol. 193:551–564.
2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hou L, Shi H, Wang M, Liu J and Liu G:
MicroRNA-497-5p attenuates IL-1β-induced cartilage matrix
degradation in chondrocytes via Wnt/β-catenin signal pathway. Int J
Clin Exp Pathol. 12:3108–3118. 2019.PubMed/NCBI
|
|
15
|
van den Bosch MH, Blom AB, van de Loo FA,
Koenders MI, Lafeber FP, van den Berg WB, van der Kraan PM and van
Lent PL: Brief report: Induction of matrix metalloproteinase
expression by synovial Wnt signaling and association with disease
progression in early symptomatic osteoarthritis. Arthritis
Rheumatol. 69:1978–1983. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cinque L, Forrester A, Bartolomeo R,
Svelto M, Venditti R, Montefusco S, Polishchuk E, Nusco E, Rossi A,
Medina DL, et al: FGF signalling regulates bone growth through
autophagy. Nature. 528:272–275. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Onuora S: Osteoarthritis: UCMA links
cartilage and bone in OA. Nat Rev Rheumatol. 13(130)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
van der Kraan PM and van den Berg WB:
Chondrocyte hypertrophy and osteoarthritis: Role in initiation and
progression of cartilage degeneration? Osteoarthritis Cartilage.
20:223–232. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Du G, Xiang C, Sang X, Wang X, Shi Y, Wang
N, Wang S, Li P, Wei X, Zhang M, et al: Histone deacetylase 4
deletion results in abnormal chondrocyte hypertrophy and premature
ossification from collagen type 2α1-expressing cells. Mol Med Rep.
22:4031–4040. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Park KW, Lee KM, Yoon DS, Park KH, Choi
WJ, Lee JW and Kim SH: Inhibition of microRNA-449a prevents
IL-1β-induced cartilage destruction via SIRT1. Osteoarthritis
Cartilage. 24:2153–2161. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academy of Sciences, Washington, DC, 2011.
|
|
22
|
Praxenthaler H, Krämer E, Weisser M, Hecht
N, Fischer J, Grossner T and Richter W: Extracellular matrix
content and WNT/β-catenin levels of cartilage determine the
chondrocyte response to compressive load. Biochim Biophys Acta Mol
Basis Dis. 1864:851–859. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sun X, Zhen X, Hu X, Li Y, Gu S, Gu Y and
Dong H: Osteoarthritis in the middle-aged and elderly in China:
Prevalence and influencing factors. Int J Environ Res Public
Health. 16(4701)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Stöve J, Huch K, Günther KP and Scharf HP:
Interleukin-1beta induces different gene expression of stromelysin,
Aggrecan and tumor-necrosis-factor-stimulated gene 6 in human
osteoarthritic chondrocytes in vitro. Pathobiology. 68:144–149.
2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Attur M, Zhou H, Samuels J, Krasnokutsky
S, Yau M, Scher JU, Doherty M, Wilson AG, Bencardino J, Hochberg M,
et al: Interleukin 1 receptor antagonist (IL1RN) gene variants
predict radiographic severity of knee osteoarthritis and risk of
incident disease. Ann Rheum Dis. 79:400–407. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li GS, Cui L and Wang GD: miR-155-5p
regulates macrophage M1 polarization and apoptosis in the synovial
fluid of patients with knee osteoarthritis. Exp Ther Med.
21(68)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhou ZB, Huang GX, Fu Q, Han B, Lu JJ,
Chen AM and Zhu L: circRNA.33186 contributes to the pathogenesis of
osteoarthritis by sponging miR-127-5p. Mol Ther. 27:531–541.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Haltmayer E, Ribitsch I, Gabner S, Rosser
J, Gueltekin S, Peham J, Giese U, Dolezal M, Egerbacher M and
Jenner F: Co-culture of osteochondral explants and synovial
membrane as in vitro model for osteoarthritis. PLoS One.
14(e0214709)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xia C, Wang P, Fang L, Ge Q, Zou Z, Dong
R, Zhang P, Shi Z, Xu R, Zhang L, et al: Activation of β-catenin in
Col2-expressing chondrocytes leads to osteoarthritis-like defects
in hip joint. J Cell Physiol. 234:18535–18543. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Merentie M, Rissanen R,
Lottonen-Raikaslehto L, Huusko J, Gurzeler E, Turunen MP, Holappa
L, Mäkinen P and Ylä-Herttuala S: Doxycycline modulates VEGF-A
expression: Failure of doxycycline-inducible lentivirus shRNA
vector to knockdown VEGF-A expression in transgenic mice. PLoS One.
13(e0190981)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hernández AR, Klein AM and Kirschner MW:
Kinetic responses of β-catenin specify the sites of Wnt control.
Science. 338:1337–1340. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Estarás C, Hsu HT, Huang L and Jones KA:
YAP repression of the WNT3 gene controls hESC differentiation along
the cardiac mesoderm lineage. Genes Dev. 31:2250–2263.
2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Held A, Glas A, Dietrich L, Bollmann M,
Brandstädter K, Grossmann TN, Lohmann CH, Pap T and Bertrand J:
Targeting β-catenin dependent Wnt signaling via peptidomimetic
inhibitors in murine chondrocytes and OA cartilage. Osteoarthritis
Cartilage. 26:818–823. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bertrand J, Kräft T, Gronau T, Sherwood J,
Rutsch F, Lioté F, Dell'Accio F, Lohmann CH, Bollmann M, Held A and
Pap T: BCP crystals promote chondrocyte hypertrophic
differentiation in OA cartilage by sequestering Wnt3a. Ann Rheum
Dis. 79:975–984. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Thomas BL, Eldridge SE, Nosrati B, Alvarez
M, Thorup AS, Nalesso G, Caxaria S, Barawi A, Nicholson JG,
Perretti M, et al: WNT3A-loaded exosomes enable cartilage repair. J
Extracell Vesicles. 10(e12088)2021.PubMed/NCBI View Article : Google Scholar
|
